COLL Stock-Based Compensation
Collegium Pharmaceutical Inc · Stock-Based Compensation
COLL Stock-Based Compensation
Latest reported$44.93Mperiod ending
COLL TTM Stock-Based Comp ($22.00K → $44.93M)
TTM stock-based compensation
High-resolution chart · PNG
COLL stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 44,928,000 | |
| 41,262,000 | |
| 41,906,000 | |
| 39,749,000 | |
| 37,255,000 | |
| 36,449,000 | |
| 32,400,000 | |
| 31,806,000 | |
| 31,516,000 | |
| 28,576,000 | |
| 27,136,000 | |
| 25,804,000 | |
| 24,154,000 | |
| 22,774,000 | |
| 22,874,000 | |
| 22,116,000 | |
| 22,687,000 | |
| 23,511,000 | |
| 24,255,000 | |
| 25,553,000 | |
| 24,770,000 | |
| 18,254,000 | |
| 16,326,000 | |
| 14,082,000 | |
| 13,054,000 | |
| 17,216,000 | |
| 16,528,000 | |
| 16,160,000 | |
| 15,949,000 | |
| 15,313,000 | |
| 13,778,000 | |
| 12,258,000 | |
| 10,432,000 | |
| 8,852,000 | |
| 7,945,000 | |
| 7,517,000 | |
| 7,058,000 | |
| 6,507,000 | |
| 5,787,000 | |
| 5,129,000 | |
| 3,991,000 | |
| 3,197,000 | |
| 2,209,000 | |
| 1,223,000 | |
| 725,000 | |
| 130,000 | |
| 22,000 |